An additional planned contrast analysis of the time course of ITGA2B levels in platelets further showed a significant decrease of ITGA2B over time in non-surviving COVID-19 patients (Figures 3B,C), which fits to the decrease in the activated integrin-αIIbβ3 complex observed in non-survivors by flow cytometry (Figure 1). Here, ITGA2B is linked to COVID-19.